Publicaciones (17) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and α-chymotrypsin-induced ocular hypertensive rabbits

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 245, Núm. 10, pp. 1559-1567

  2. An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder [10]

    Journal of Clinical Psychopharmacology

  3. CB1 cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices

    Neuropharmacology, Vol. 52, Núm. 2, pp. 617-625

  4. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 852, Núm. 1-2, pp. 519-528

  5. Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin

    EMBO Journal, Vol. 26, Núm. 19, pp. 4189-4202

  6. Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Núm. 5, pp. 337-347

  7. Guanidine and 2-aminoimidazoline aromatic derivatives as α2-adrenoceptor antagonists, 1: Toward new antidepressants with heteroatomic linkers

    Journal of Medicinal Chemistry, Vol. 50, Núm. 18, pp. 4516-4527

  8. Implicación de los polimorfismos del gen TPH2 en el suicidio consumado

    SEG 2007: libro de resúmenes

  9. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats

    International Journal of Pharmaceutics, Vol. 343, Núm. 1-2, pp. 69-78

  10. Mecanismos neurofisiológicos implicados en los efectos farmacológicos de los cannabinoides

    Hablemos del cannabis: avances en drogodependencias (Servicio de Publicaciones = Argitalpen Zerbitzua), pp. 133-150

  11. Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar

    Pharmaceutical Research, Vol. 24, Núm. 7, pp. 1299-1308

  12. On the search of new I2-IBS aliphatic ligands: Bis-guanidino carbonyl derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 21, pp. 6009-6012

  13. Path to understanding the pathophysiology of fragile X syndrome

    Future Neurology, Vol. 2, Núm. 5, pp. 567-575

  14. Phospholipase D signaling: Orchestration by PIP2 and small GTPases

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Núm. 5-6, pp. 399-411

  15. Polimorfismo del322-325 del adrenoceptor alfa2C en enfermedades psiquiátricas

    SEG 2007: libro de resúmenes

  16. Synthesis and pharmacological evaluation of chlorinated N-alkyl-3- and -5-(2-hydroxyphenyl)pyrazoles as CB 1 cannabinoid ligands

    Monatshefte fur Chemie, Vol. 138, Núm. 8, pp. 797-811

  17. The pathophysiology of fragile X syndrome

    Annual Review of Genomics and Human Genetics, Vol. 8, pp. 109-129